Related Experiment Video
Updated: Jun 5, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNAs in chronic lymphocytic leukemia
Brian P Ward1, Gregory J Tsongalis, Prabhjot Kaur
1Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Abstract:
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. Recent research, conducted primarily in basic science laboratories, has indicated a role for microRNAs (miRNAs) in the pathogenesis and prognosis of this disease. MiRNAs are small, non-coding, functional RNAs, that mediate post-transcriptional inhibition of messenger RNAs. Because miRNA expression levels in CLL patients differ from that of normal patients, there may be a role for these novel small molecules as biomarkers in this disease.
Insights
MicroRNAs (miRNAs) show promise as biomarkers for chronic lymphocytic leukemia (CLL). Differences in miRNA expression in CLL patients suggest their role in disease pathogenesis and prognosis, offering new diagnostic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a prevalent hematologic malignancy in Western countries.
- MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly implicated in cancer development.
- Emerging research suggests a potential role for miRNAs in CLL pathogenesis and predicting patient outcomes.
Purpose of the Study:
- To investigate the potential of microRNAs (miRNAs) as biomarkers in chronic lymphocytic leukemia (CLL).
- To explore the differential expression of miRNAs in CLL patients compared to healthy individuals.
Main Methods:
- Analysis of miRNA expression profiles in patient samples.
- Comparison of miRNA levels between CLL patients and normal controls.
Main Results:
- Significant differences in miRNA expression were observed between CLL patients and normal individuals.
- These distinct expression patterns suggest a role for miRNAs in the molecular mechanisms underlying CLL.
Conclusions:
- MicroRNA expression levels may serve as valuable biomarkers for diagnosing and potentially prognosing chronic lymphocytic leukemia (CLL).
- Further research into miRNAs could lead to novel therapeutic strategies for CLL.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
